Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1991 Mar 16;302(6777):605–606. doi: 10.1136/bmj.302.6777.605

What should be done about asymptomatic hypercholesterolaemia?

G R Thompson
PMCID: PMC1675486  PMID: 1826458

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Garber A. M., Sox H. C., Jr, Littenberg B. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989 Apr 15;110(8):622–639. doi: 10.7326/0003-4819-110-8-622. [DOI] [PubMed] [Google Scholar]
  2. Mann J. I., Lewis B., Shepherd J., Winder A. F., Fenster S., Rose L., Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1702–1706. doi: 10.1136/bmj.296.6638.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Puchois P., Kandoussi A., Fievet P., Fourrier J. L., Bertrand M., Koren E., Fruchart J. C. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 1987 Nov;68(1-2):35–40. doi: 10.1016/0021-9150(87)90091-8. [DOI] [PubMed] [Google Scholar]
  4. Seed M., Hoppichler F., Reaveley D., McCarthy S., Thompson G. R., Boerwinkle E., Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990 May 24;322(21):1494–1499. doi: 10.1056/NEJM199005243222104. [DOI] [PubMed] [Google Scholar]
  5. Shepherd J., Betteridge D. J., Durrington P., Laker M., Lewis B., Mann J., Miller J. P., Reckless J. P., Thompson G. R. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1245–1246. doi: 10.1136/bmj.295.6608.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sniderman A. D., Silberberg J. Is it time to measure apolipoprotein B? Arteriosclerosis. 1990 Sep-Oct;10(5):665–667. doi: 10.1161/01.atv.10.5.665. [DOI] [PubMed] [Google Scholar]
  7. Vega G. L., Grundy S. M. Does measurement of apolipoprotein B have a place in cholesterol management? Arteriosclerosis. 1990 Sep-Oct;10(5):668–671. doi: 10.1161/01.atv.10.5.668. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES